BRIEF published on 04/07/2025 at 14:05, 9 months 27 days ago L'audience de Newsmax connaît une croissance de 50 % au premier trimestre 2025 Informations Par Câble T1 2025 Croissance De Newsmax Augmentation Du Nombre De Téléspectateurs Introduction En Bourse De NMAX
BRIEF published on 04/07/2025 at 14:05, 9 months 27 days ago GPO Plus Reports Record Quarterly Revenue with Improved Margins Quarterly Revenue Gross Margins Operating Expenses Warehouse Upgrades New Sales Channels
BRIEF published on 04/07/2025 at 14:05, 9 months 27 days ago GPO Plus annonce un chiffre d'affaires trimestriel record avec des marges améliorées Dépenses D'exploitation Marges Brutes Revenus Trimestriels Améliorations De L'entrepôt Nouveaux Canaux De Vente
BRIEF published on 04/07/2025 at 14:05, 9 months 27 days ago AIML Announces Updated Terms for Private Placement Offering Private Placement Common Shares Warrants AI/ML Innovations Investment Offering
BRIEF published on 04/07/2025 at 14:05, 9 months 27 days ago AIML annonce les conditions mises à jour de son offre de placement privé Placement Privé Actions Ordinaires Mandats Innovations En IA/ML Offre D'investissement
BRIEF published on 04/07/2025 at 13:35, 9 months 27 days ago Orogen Royalties Updates on Ermitaño Royalty and Navidad Vein Potential Ermitaño Mine Orogen Royalties Sonora, Mexico Navidad Vein Gold And Silver Resources
BRIEF published on 04/07/2025 at 13:35, 9 months 27 days ago Mises à jour des redevances orogènes sur la redevance Ermitaño et le potentiel de la veine Navidad Sonora, Mexique Mine D'Ermitaño Veine De Navidad Redevances D'Orogen Ressources En Or Et En Argent
BRIEF published on 04/07/2025 at 13:05, 9 months 27 days ago CureVac Advances mRNA Immunotherapy for Lung Cancer FDA Clearance Clinical Trial CureVac MRNA Immunotherapy SqNSCLC
BRIEF published on 04/07/2025 at 13:05, 9 months 27 days ago CureVac fait progresser l'immunothérapie par ARNm pour le cancer du poumon Essai Clinique Autorisation De La FDA CureVac CPNPC Immunothérapie Par ARNm
BRIEF published on 04/07/2025 at 13:05, 9 months 27 days ago Moderna to Present Extensive Research on Infectious Diseases Moderna MRNA Vaccines Infectious Diseases ESCMID 2025 Research Presentations
Published on 02/05/2026 at 09:05, 2 hours 45 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 10 hours 15 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 11 hours 50 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 13 hours 25 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 11:47, 3 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:45, 5 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 02/05/2026 at 11:30, 20 minutes ago Linde Reports Full-Year and Fourth-Quarter 2025 Results (Earnings Release Tables Attached)
Published on 02/05/2026 at 11:30, 20 minutes ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 20 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 17 hours 46 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 17 hours 46 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 18 hours 5 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
